Medicina

2017

1. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

   European Journal of Heart Failure, Vol. 19, Núm. 1, pp. 9-42

2. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS

   Russian Journal of Cardiology

3. 2016 update of the EULAR recommendations for the management of early arthritis

   Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 948-959

4. 2017 ESC/EACTS Guidelines for the management of valvular heart disease

   European Heart Journal, Vol. 38, Núm. 36, pp. 2739-2786

5. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System

   JACC: Cardiovascular Interventions, Vol. 10, Núm. 2, pp. 160-167

6. A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial

   American Heart Journal, Vol. 184, pp. 121-132

7. A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit

   Journal of Clinical Virology, Vol. 95, pp. 76-83

8. A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay

   Journal of Clinical Virology, Vol. 92, pp. 75-82

9. A Girl with Gray Hair and Pyogenic Infections

   Pediatric Dermatology, Vol. 34, Núm. 5, pp. 607-608

10. A Mediterranean diet with additional extra virgin olive oil and pistachios reduces the incidence of gestational diabetes mellitus (GDM): A randomized controlled trial: The St. Carlos GDM prevention study

    PLoS ONE, Vol. 12, Núm. 10

11. A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma

    Journal of Molecular Diagnostics, Vol. 19, Núm. 1, pp. 99-106

12. A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse

    Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3035-3044

13. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

    Kidney International Reports, Vol. 2, Núm. 5, pp. 800-810

14. A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer

    Clinical Lung Cancer

15. A Reversible Cause of Acute Right Ventricular Failure After Heart Transplant

    Revista Espanola de Cardiologia, Vol. 70, Núm. 8, pp. 677-679

16. A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0-10 visual analogue scales

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 5, pp. S21-S25

17. A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294

18. A consensus statement on the gender perspective in lung cancer

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 527-535

19. A data mining approach using cortical thickness for diagnosis and characterization of essential tremor /692/53/2421 /692/617/375/346 /129 /141 /123 article

    Scientific Reports, Vol. 7, Núm. 1

20. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624